Susceptibility to serious skin and subcutaneous tissue disorders and skin tissue distribution of sodium-dependent glucose co-transporter type 2 (SGLT2) inhibitors

Objectives: In Japan, sodium-glucose co-transporter type 2 (SGLT2) inhibitors have been reported to be associated with serious skin and subcutaneous tissue disorders. A post-marketing surveillance (PMS) study suggested that the association was specific for ipragliflozin and, to a lesser extent for d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakaeda, Toshiyuki, Kobuchi, Shinji, Yoshioka, Ryosuke, Haruna, Mariko, Takahata, Noriko, Ito, Yukako, Sugano, Aki, Fukuzawa, Kazuki, Hayase, Toshiki, Hayakawa, Taro, Nakayama, Hideo, Takaoka, Yutaka, Tohkin, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036094/
https://www.ncbi.nlm.nih.gov/pubmed/30008607
http://dx.doi.org/10.7150/ijms.22224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036094/
https://www.ncbi.nlm.nih.gov/pubmed/30008607
http://dx.doi.org/10.7150/ijms.22224

Ejemplares similares